BVF Inc’s Kronos Bio KRON Stock Holding History

BVF Inc’s Portfolio KRON Stock Details KRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,905,043	Closed	-$3.78M	–	64
2024 Q1	$3.78M	Hold	2,905,043	–	–	0.1%	52
2023 Q4	$3.63M	Hold	2,905,043	–	–	0.09%	58
2023 Q3	$3.78M	Buy	2,905,043 +91,558	+3%	+$148K	0.1%	56
2023 Q2	$4.84M	Buy	+2,813,485	New	+$4.47M	0.13%	54

Other funds holding KRON

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

PCIG

Partners Capital Investment Group Boston, Massachusetts $2.83B AUM 20.31% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

BVF Inc's KRON Position: Q2 2024 in Review

BVF Inc sold out of Kronos Bio (KRON) in Q2 2024, closing a stake of 2,905,043 shares — an estimated $3.78M sold.

BVF Inc first reported a position in KRON in Q2 2023 and held it in 4 quarters. The position peaked at $4.84M in Q2 2023. 56 funds tracked by Wall St. Rank hold KRON as of Q2 2024.

BVF Inc reported no remaining Kronos Bio position as of Q2 2024 after selling out during the quarter.
BVF Inc sold 2,905,043 Kronos Bio shares in Q2 2024, an estimated $3.78M.
BVF Inc first reported a position in Kronos Bio in Q2 2023 and held it in 4 quarters.
BVF Inc's Kronos Bio position peaked at $4.84M in Q2 2023.
56 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2024.

Based on BVF Inc's 13F filing for Q2 2024, filed 14 Aug 2024.